Sono-Tek Corporation filings document formal disclosures for a New York operating company that manufactures precision ultrasonic coating systems. Recent Form 8-K reports furnish quarterly operating results, Regulation FD materials, annual meeting presentations, and press releases tied to significant medical device coating system orders. Proxy and shareholder-meeting filings cover board elections, director service changes, auditor ratification, security-holder voting results, and governance matters.
Maria Kuha, Vice President and director of Sono-Tek Corporation (SOTK), exercised options on 08/21/2025 to acquire 12,195 shares of common stock at an exercise price of $3.25 per share. The options become exercisable on 08/21/2026 and expire 08/21/2035. Following the transaction, Ms. Kuha directly beneficially owns 27,796 shares of Sono-Tek common stock.
Christopher Cichetti, a Vice President and director of Sono-Tek Corporation (SOTK), reported receipt of 21,951 stock options on 08/21/2025. The options have an exercise price of $3.25 per share, are exercisable beginning 08/21/2026 and expire on 08/21/2035. After this grant, Mr. Cichetti beneficially owns 79,763 shares of common stock on a direct basis. The Form 4 was signed and dated 08/22/2025.
Sono-Tek Corporation (SOTK) insider filing: CEO Stephen R. Harshbarger reported an option grant on 08/21/2025. The report shows acquisition of 29,268 Sono-Tek options with an exercise price of $3.25 per share.
The options become exercisable on 08/21/2026 and expire on 08/21/2035. Following the reported transaction, Mr. Harshbarger beneficially owns 83,184 shares (direct).
Sono-Tek Corporation filed a current report describing information shared at its annual meeting of shareholders. On August 21, 2025, the company provided a presentation at the meeting, which is furnished as Exhibit 99.1. The disclosure is made under the sections for results of operations and financial condition and for Regulation FD, but the materials are expressly treated as “furnished” rather than “filed,” meaning they are not subject to certain Exchange Act liabilities and are not automatically incorporated into other securities law filings.
Stephen J. Bagley, CFO of Sono-Tek Corporation (SOTK), reported multiple open-market sales of common stock on August 18-19, 2025. The filings show four dispositions at prices between $3.34 and $3.36 per share, reducing his direct holdings stepwise to 34,254 shares. The Form 4 is signed and filed to disclose these changes in beneficial ownership.
Stephen J. Bagley, CFO of Sono-Tek Corporation, reported a sale of 350 shares of common stock on 08/07/2025 at $3.33 per share. After the transaction he directly beneficially owns 36,147 shares. The Form 4 shows only this routine officer sale and lists no derivative transactions or other material changes to his ownership.
Sono-Tek Corp. (SOTK) mailed its DEF 14A for the 21 Aug 2025 AGM (record date 21 Jul 2025, Milton NY, 10 a.m.). Shareholders will:
- Elect four directors (Coccio, Riemer, Harshbarger, Warshaw) to 2027.
- Ratify CBIZ CPAs as independent auditor, replacing Marcum after its business sale.
- Cast advisory votes on NEO compensation and on pay-vote frequency (board backs three-year cycle).
Board consists of eight members—six are NASDAQ-defined independent. Dr Christopher Coccio became Executive Chair in Jan 2024; R. Stephen Harshbarger is CEO. FY 2025 NEO pay: CEO $385.5k (incl. $60k option grant at $4.12), CFO $254.6k, COO $334.8k. Non-employee directors earn $2,500 per meeting plus 5,333 options.
Equity plans: 2013 Plan (211k options outstanding, closed) and 2023 Plan (220k outstanding, 2.5 m share limit). Change-of-control severance equals two years’ comp (CEO estimate $659k). Outstanding shares total 15.73 m; Emancipation Management and related entities own 34.8%. Audit fees FY 2025 were $185k; no tax or other fees. Board recommends voting FOR all proposals.